Hints and tips:
...India, which passed 5m cases, will buy 100m doses of Russia’s Sputnik-V vaccine candidate. Eli Lilly’s antibody treatment reduced hospitalisations....
...The online format enabled guest lectures from executives such as Daniel Skovronsky, chief scientific officer at pharmaceuticals company Eli Lilly, who spoke about the race for a Covid-19 vaccine....
...It has also signed deals with Vir Biotechnology to produce Covid-19 antibody products and with Eli Lilly and AstraZeneca to produce Covid-19 treatments. Song Jung-a 74....
...In sifting through the S&P 500, it has chosen to only include companies with 0-45 per cent tax rates, so as to eliminate bizarre outliers such as pharmaceutical company Eli Lilly, who reported a tax rate...
...The government has vowed to tackle the price of cancer medicines, threatening revenues for multinationals such as Eli Lilly, Roche and Novartis....
...Rival Eli Lilly announced job cuts and a focus on new medicines while AstraZeneca was boosted by good news on its cancer pipeline....
...Lilly mulls spin-off or sale of animal health business (FastFT) Cargill ramps up animal nutrition business with Diamond V deal (FastFT) Asian buyers tap into ‘pampered pooch’ market (FT) ICE to buy bond...
...They also point to other potentially huge advances: if solanezumab, an Alzheimer’s drug being developed by Eli Lilly, is successful when data from a large trial are published later this year, it would be...
...Mr Anderson also highlighted potential competition from similar drugs under development by Eli Lilly and Novartis....
...But a wide coalition of other interests has now come out strongly against the proposed law: they include pharmaceuticals companies such as Eli Lilly and technology companies like Qualcomm, along with 3M...
...Separately on Tuesday, Eli Lilly reported declining fourth-quarter profits and revenues, as it faced competition from generic copies of its drugs....
...“Overall, a reasonable quarter for the company, yet for many investors, it is the longer term financial outlook that matters more and here, Eli Lilly still looks challenged,” said Timothy Anderson, analyst...
...on Eli Lilly as an investment opportunity,” said Timothy Anderson, pharmaceutical analyst at Bernstein Research....
...Masterpieces of Chinese Painting: 700-1900, edited by Zhang Hongxing, V&A Publishing, RRP£40/$60 The world’s oldest painting tradition explored in the glorious catalogue to the V&A’s current, once-in-a-lifetime...
...Other companies that will be represented at Friday’s meeting include Bank of America, Johnson & Johnson, Caterpillar, United Technologies, Wal-Mart, General Electric, Procter & Gamble, Cisco and Eli Lilly...
International Edition